Results

Total Results: 1,612 records

Showing results for "reduces".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-evidence-summary-corticosteroids-asthma.pdf
    October 01, 2017 - inhaled corticosteroids and long-acting beta-agonists together as controller and quick relief therapy reduces … SABA prn at the onset of a URI • Reduces the risk of exacerbation requiring oral corticosteroids (moderate … ICS and LABA as controller at the same ICS dose • Reduces the risk of exacerbations measured as a … ICS and LABA as controller at the same ICS dose • Reduces: – The risk of exacerbations defined as … ICS and LABA as controller at a higher ICS dose • Reduces the risk of exacerbations defined as a composite
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-roadmap-interventions.pdf
    November 01, 2020 - mortality,” “probably reduces,” “may reduce,” and “it is uncertain whether the intervention reduces… … [outcome] (moderate certainty evidence) [Intervention] probably slightly improves/reduces [outcome … /increases outcome X results in a reduction/increase in outcome Small important effect X reduces … /increases outcome X probably reduces/increases outcome X likely results in a reduction/increase … /increases outcome slightly X likely reduces/increases outcome slightly X probably results in a
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_clinician.pdf
    January 01, 2017 - for Acute Gout Attack: Key Findings Strategy N Studies N Subjects Finding SOE Colchicine 2 RCTs 229 Reduces … as much as NSAIDs ��� Animal-derived ACTH (not commonly used in clinical practice) 2 RCTs 107 Reduces … Strategy N Studies N Subjects Finding SOE Management of hyperuricemia ULT vs. placebo 4 RCTs 1378 Reduces … the risk of acute gout attacks within the first 6 months ��� 1 open-label extension study NR Reduces … treatment Treating to a specific target serum urate level 1 systematic review and 8 studies NR Reduces
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-evidence-summary-immunotherapy-asthma.pdf
    March 01, 2018 - Key Messages • Subcutaneous immunotherapy reduces use of long-term control medications. … • Sublingual immunotherapy improves asthma symptoms, quality of life and FEV1, and reduces the use … Key Points • SCIT reduces the need for long-term control medication (moderate strength of evidence [ … Long-term medication 6 RCTs 5, 6, 8-11 N=404 Medium Consistent Direct Precise Undetected SCIT reduces … SLIT improves asthma symptoms, reduces long-term control medication use, improves disease- specific
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nom-length-stay-supplement.pdf
    June 27, 2019 - In addition: • Reducing LOS reduces the risk of patient harms in the hospital and the cost of care
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-233-diverticulitis-evidence-summary.pdf
    October 01, 2020 - complicated or smoldering/frequently recurrent (after uncomplicated) diverticulitis, elective surgery reduces … Elective surgery to prevent recurrent diverticulitis: There is high SoE that elective surgery reduces
  7. Gout Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
    March 01, 2016 - • Low-strength evidence supports the finding that treating to a specific target serum urate level reduces … We based our moderate SoE rating on the high strength evidence that ULT reduces serum urate, that serum … We thus concluded that over time, possibly by 1 year from initiation of therapy, ULT reduces the risk … Longer term studies will be needed to assess the degree to which ULT reduces acute gout attacks relative … High Animal-derived ACTH formulation reduces pain • Biologic rationale (anti- inflammatory action)
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdf
    January 01, 2010 - The strength of evidence is low that subcutaneous immunotherapy reduces combined symptom-medication … The strength of evidence was moderate that subcutaneous immunotherapy reduces asthma symptoms. … The strength of evidence is high that sublingual immunotherapy reduces asthma symptoms. … The strength of evidence is high that sublingual immunotherapy reduces asthma symptoms. … There is high-grade evidence that sublingual immunotherapy reduces asthma symptoms.
  9. effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - Extended followup suggests that RP may reduce mortality and probably reduces metastases over a very … For men with higher risk disease who select EBR, the addition of AD reduces mortality but may increase
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/living-systematic-reviews-full-text-articles-white-paper.pdf
    January 01, 2024 - Cannabis significantly reduces the use of prescription opioids and improves quality of life in authorized … Medical cannabis use reduces opioid prescriptions in patients with chronic back pain. … Medical cannabis use reduces opioid prescriptions in patients with Osteoarthritis. … Medical cannabis use reduces opioid prescriptions in patients with chronic back pain. … Medical Cannabis use reduces opioid prescriptions in patients with osteoarthritis.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/procalcitonin_executive.pdf
    October 01, 2012 - Early initiation of appropriate antibiotics and goal-directed therapies reduces mortality. … There is high strength of evidence (Table B) that procalcitonin guidance reduces antibiotic use. … There is high strength of evidence that procalcitonin guidance reduces antibiotic duration and prescription … Our systematic review found that procalcitonin guidance reduces antibiotic use for adult patients in … Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive
  12. effectivehealthcare.ahrq.gov/sites/default/files/cer-239-episodic-migraine-comments.pdf
    December 29, 2020 - A relevant meta-analysis found that IV Mg reduces acute migraine attacks within 15 - 45 minutes, 120
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
    March 01, 2012 - daily, particularly when given with calcium, reduces the risk of hip and nonvertebral fractures among … Low Wrist fractures: alendronate reduces the risk of wrist fractures among postmenopausal women with … Denosumab High Denosumab reduces the risk of vertebral, nonvertebral and hip fractures in postmenopausal … PTH (teriparatide) High Teriparatide reduces the risk of vertebral fractures in postmenopausal women … SERMs (raloxifene) High Raloxifene reduces the risk of vertebral fractures among postmenopausal women
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
    August 01, 2017 - Global Outcomes Sleep Outcomes CBT-Ib Improves (��� to ���) Improves (���) May improve (���) Reduces … Orexin Receptor Antagonists Suvorexant Improves (���) Improves latency and total sleep time (���) Reduces
  15. effectivehealthcare.ahrq.gov/sites/default/files/introduction-to-user-guide-overview.pptx
    January 01, 2013 - development of scientifically rigorous observational research that produces valid new knowledge and reduces … development of scientifically rigorous observational research that produces valid new knowledge and reduces
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
    October 01, 2010 - Conclusions For the uses examined, current evidence does not show that off-label use of rFVIIa reduces
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-270-bimp-disposition-comments.pdf
    September 18, 2024 - Trauma informed therapy may be useful in reducing chronic migraines if it reduces PTSD symptoms.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
    April 01, 2019 - • Long-term alendronate reduces radiographic vertebral and nonvertebral fractures in women with osteoporosis … ; long-term zoledronate reduces vertebral and nonvertebral fractures in women with osteopenia or osteoporosis … • In women with osteoporosis, long-term raloxifene reduces vertebral fractures, but not hip or nonvertebral … • Continuing bisphosphonates after 3–5 years versus discontinuation reduces some measures of vertebral … Raloxifene reduces risk of vertebral fractures [corrected] in postmenopausal women regardless of prior
  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_executive.pdf
    September 01, 2009 - • Tamoxifen reduces breast cancer outcomes in subgroups evaluated in prevention trials based on age … • Raloxifene reduces breast cancer outcomes in subgroups evaluated in prevention trials based on age
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
    October 05, 2012 - primary critique is that the authors conclude rather definitively (high evidence) that PCT guidance reduces … If a PCT-guided algorithm reduces antibiotic usage in a study setting, whether or not an institution … Specifically, I am concerned about both the conclusion related to effectiveness (reduces Abx use) and … PR (#5) General Comments Strength of evidence was judged to be high that procalcitonin guidance reduces … In this case, any protocol that reduces Abx will be deemed safe, because mortality will not rise.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: